Get the latest Science News and Discoveries

FDA approves the first treatment for nasopharyngeal carcinoma, a rare cancer that originates in the nasopharynx. The drug (toripalimab-tpzi) is a next-generation, programmed death receptor-1 monoclonal antibody. Because of the tumor's location (behind the nose), surgery is not usually an option.


Get the Android app

Or read this on r/EverythingScience

Read more on:

Photo of tpzi


Photo of tumor


Photo of location


Related news:

News photo

FDA Issues Eye Drops Warning After Deadly Outbreak of Bacterial Infections

News photo

Scientists build on artificial intelligence to create next-generation gastric acid treatment

News photo

Mechanics of breast cancer metastasis discovered, offering target for treatment